Evidence map›Paper›PMID 24041575›Full record

ArticleBlood2013

Nfix is a novel regulator of murine hematopoietic stem and progenitor cell survival.

Per Holmfeldt, Jennifer Pardieck, Anjelica C Saulsberry, Satish Kumar Nandakumar, David Finkelstein, John T Gray, Derek A Persons, Shannon McKinney-Freeman

Open access · bronzeAbstract read
In one paragraph

Article in Blood, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
2.0field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 57 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. NFIXing Cancer: The Role of NFIX in Oxidative Stress Response and Cell Fate.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

Per HolmfeldtDepartment of Hematology and.
Jennifer Pardieck
Anjelica C Saulsberry
Satish Kumar Nandakumar
David Finkelstein
John T Gray
Derek A Persons
Shannon McKinney-Freeman
St. Jude Children's Research Hospital · US

Funding

Viral Vector Technology (VVTSR)P30CA021765 · NCI · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI CHARLES ROBERTS · 1985 to 2026
$166.9M
Characterization of embryonic stem cell-derived hematopoietic stem cellsK01DK080846 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MCKINNEY-FREEMAN, SHANNON L · 2008 to 2012
$771k
Functional study of novel transcriptional regulators of hematopoietic stem cellsR03DK093731 · NIDDK · ST. JUDE CHILDREN'S RESEARCH HOSPITAL · PI MCKINNEY-FREEMAN, SHANNON L · 2012 to 2012
$88k
NCI NIH HHS P30 CA021765NIDDK NIH HHS K01 DK080846NIDDK NIH HHS K01DK080846NIDDK NIH HHS R03 DK093731NIDDK NIH HHS R03DK093731
6 · The paper itself

Abstract

Hematopoietic stem cells are both necessary and sufficient to sustain the complete blood system of vertebrates. Here we show that Nfix, a member of the nuclear factor I (Nfi) family of transcription factors, is highly expressed by hematopoietic stem and progenitor cells (HSPCs) of murine adult bone marrow. Although short hairpin RNA-mediated knockdown of Nfix expression in Lineage(-)Sca-1(+)c-Kit(+) HSPCs had no effect on in vitro cell growth or viability, Nfix-depleted HSPCs displayed a significant loss of colony-forming potential, as well as short- and long-term in vivo hematopoietic repopulating activity. Analysis of recipient mice at 4 to 20 days posttransplant revealed that Nfix-depleted HSPCs are established in the bone marrow, but fail to persist due to increased apoptotic cell death. Gene expression profiling of Nfix-depleted HSPCs reveals that loss of Nfix expression in HSPCs is concomitant with a decrease in the expression of multiple genes known to be important for HSPCs survival, such as Erg, Mecom, and Mpl. These data reveal that Nfix is a novel regulator of HSPCs survival posttransplantation and establish a role for Nfi genes in the regulation of this cellular compartment.

Indexed as

Adult Stem CellsAnimalsAntigens, LyApoptosisBone Marrow CellsCell SurvivalGene Expression ProfilingGene Expression RegulationHematopoiesisHematopoietic Stem CellsHematopoietic Stem Cell TransplantationMembrane ProteinsMiceNFI Transcription FactorsOncogene ProteinsProto-Oncogene Proteins c-kitAntigens, LyERG protein, mouseLy6a protein, mouseMembrane ProteinsMpl protein, mouseNFI Transcription FactorsNfix protein, mouseOncogene ProteinsProto-Oncogene Proteins c-kitReceptors, ThrombopoietinRNA, Small InterferingTranscriptional Regulator ERGTranscription Factors

Identifiers

PMID24041575
PMCPMC3811173
OpenAlexW1972259419

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.